Morphocell Technologies is a regenerative medicine company founded by clinicians and scientists to develop solutions to clinical needs that impact adults and children worldwide,


We're focused on the commercial development of stem cell-derived engineered tissues aimed at treating costly and often fatal liver diseases. 

Based in Montreal, Canada, Morphocell is currently conducting preclinical work ahead of first-in-human clinical trials. 


Explore investment and co-development opportunities with us by contacting